GrantMetric / New Grants / November 2024
🆕 MONTHLY GRANT TRACKER

New Federal Grants — November 2024

102 federal grant opportunities posted in November 2024, sourced live from Grants.gov. Covers health, technology, environment, energy, defense, and more.

Posted in November 2024: 102 // Source: Grants.gov // Updated: Daily
← October 2024 November 2024 December 2024 →

About November 2024 Federal Grant Postings

Federal agencies post Notices of Funding Opportunity (NOFOs) throughout the year. Grants posted in November 2024 represent active funding from NIH, NSF, DOD, EPA, USDA, HHS, DOE, and other federal agencies. Each posting includes the award ceiling, eligibility requirements, and application deadline — all sourced directly from Grants.gov.

Newly posted grants are typically open for 30–90 days. High-priority programs from NIH and DOD often close faster — monitoring monthly postings ensures your organization does not miss time-sensitive opportunities. Bookmark this page and check back as new grants are added throughout the month.

How to use this list: Click any grant to view the full funding opportunity details including award ceiling, eligibility criteria, application instructions, and AI-generated briefing. Use the sector tags to identify relevant programs. All close dates are displayed in MM/DD/YYYY format and sourced directly from the official Grants.gov registry.

Grants Posted in November 2024 (102)

PA-25-245 09/07/2026
Alcohol Health Services Research (R01 Clinical Trial Optional)
Agency HHS-NIH11

The National Institute on Alcohol Abuse and Alcoholism solicits applications for an R01 Clinical Trial Optional mechanis...

Posted: 11/27/2024 View Details →
PA-25-163 09/07/2026
Alcohol Treatment, Pharmacotherapy, and Recovery Research (R01 Clinical Trial Required)
Agency HHS-NIH11

The National Institute on Alcohol Abuse and Alcoholism solicits applications for an R01 Clinical Trial Required mechanis...

Posted: 11/27/2024 View Details →
PAR-25-192 09/07/2026
Alcohol Health Services Research (R34 Clinical Trial Optional)
Agency HHS-NIH11

The National Institute on Alcohol Abuse and Alcoholism solicits applications for an R34 Clinical Trial Optional mechanis...

Posted: 11/27/2024 View Details →
PAR-25-193 09/07/2026
Alcohol Treatment, Pharmacotherapy, and Recovery Research (R34 Clinical Trial required)
Agency HHS-NIH11

The National Institute on Alcohol Abuse and Alcoholism solicits applications for an R34 Clinical Trial Optional mechanis...

Posted: 11/27/2024 View Details →
PAR-25-183 10/15/2027
Early Stage Testing of Pharmacologic or Neuromodulatory Device-based Interventions for the Treatment of Mental Disorders (R33- Clinical Trial Required)
Agency HHS-NIH11

NIMH requires an experimental therapeutics approach for the development and testing of therapeutic interventions, in whi...

Posted: 11/26/2024 View Details →
PAR-25-285 10/15/2027
Effectiveness Trials to Test Mental Health System Interventions (R61/R33 Clinical Trial Required)
Agency HHS-NIH11

This R61/R33 concept complements NIMHs suite of clinical trial NOFOs by supporting feasibility and infrastructure develo...

Posted: 11/26/2024 View Details →
PAR-25-177 10/15/2027
Full-Scale Hybrid Effectiveness-Implementation Trials for Mental Health Interventions (R01 - Clinical Trial Required)
Agency HHS-NIH11

Clinical Trials to Test the Effectiveness of Treatment, Preventive, and Services Interventions (R01 Clinical Trial Requi...

Posted: 11/26/2024 View Details →
PAR-25-181 10/15/2027
Development of Psychosocial Therapeutic and Preventive Interventions for Mental Disorders (R33 Clinical Trial Required)
Agency HHS-NIH11

Development of Psychosocial Therapeutic and Preventive Interventions for Mental Disorders (R33 Clinical Trial Required)....

Posted: 11/26/2024 View Details →
PAR-25-178 10/15/2027
Pilot Hybrid Effectiveness-Implementation Trials for Mental Health Interventions (R01 Clinical Trial Required)
Agency HHS-NIH11

Pilot Effectiveness Trials for Treatment, Preventive and Services Interventions (R01 Clinical Trial Required). As part o...

Posted: 11/26/2024 View Details →
PAR-25-179 10/15/2027
Confirmatory Efficacy Clinical Trials of Non-Pharmacological and Pharmacological Interventions for Mental Disorders (R01 Clinical Trial Required)
Agency HHS-NIH11

Confirmatory Efficacy Clinical Trials of Non-Pharmacological Interventions for Mental Disorders (R01 Clinical Trial Requ...

Posted: 11/26/2024 View Details →
PAR-25-182 10/15/2027
Development of Psychosocial Therapeutic and Preventive Interventions for Mental Disorders (R61/R33 Clinical Trial Required)
Agency HHS-NIH11

Development of Psychosocial Therapeutic and Preventive Interventions for Mental Disorders (R61/R33 Clinical Trial Requir...

Posted: 11/26/2024 View Details →
PAR-25-180 10/15/2027
First in Human and Early Stage Clinical Trials of Novel Investigational Drugs or Neuromodulatory Device-based Interventions for Psychiatric Disorders (U01 Clinical Trial Required)
Agency HHS-NIH11

The purpose of this Notice of Funding Opportunity (NOFO) is to encourage cooperative agreement applications to support e...

Posted: 11/26/2024 View Details →
PAR-25-184 10/15/2027
Early Stage Testing of Pharmacologic or Neuromodulatory Device-based Interventions for the Treatment of Mental Disorders (R61/R33 Clinical Trial Required)
Agency HHS-NIH11

NIMH requires an experimental therapeutics approach for the development and testing of therapeutic interventions, in whi...

Posted: 11/26/2024 View Details →
PAR-25-272 05/07/2027
New Approaches for Measuring Brain Changes Across Longer Timespans (R21 Clinical Trial Optional)
Agency HHS-NIH11

The purpose of this funding opportunity is to encourage multidisciplinary investigators to submit applications developin...

Posted: 11/25/2024 View Details →
PAR-25-288 01/07/2028
Navigator Emergency Department Diversion Models for Non-Urgent Mental Health Concerns (R34 Clinical Trial Required)
Agency HHS-NIH11

The purpose of this NOFO is to build research about the effectiveness, implementation, and optimization of family naviga...

Posted: 11/25/2024 View Details →
PAR-25-159 01/07/2027
Prevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (R34 Clinical Trial Optional)
Agency HHS-NIH11

This Notice of Funding Opportunity (NOFO) for R34 planning grant applications focuses on prevention and intervention str...

Posted: 11/25/2024 View Details →
PAR-25-279 05/07/2027
New Approaches for Measuring Brain Changes Across Longer Timespans (R01 Clinical Trial Optional)
Agency HHS-NIH11

The purpose of this funding opportunity is to encourage multidisciplinary investigators to develop new approaches or app...

Posted: 11/25/2024 View Details →
PAR-25-289 01/07/2028
Navigator Emergency Department Diversion Models for Non-Urgent Mental Health Concerns (R01 Clinical Trial Required)
Agency HHS-NIH11

The purpose of this NOFO is to build research about the effectiveness, implementation, and optimization of family naviga...

Posted: 11/25/2024 View Details →
PAR-25-292 01/07/2028
The Role of Work in Health Disparities in the U.S. (R01 Clinical Trials Optional)
Agency HHS-NIH11

The purpose of this Notice of Funding Opportunity (NOFO) is to support innovative population-based research that can con...

Posted: 11/25/2024 View Details →
PAR-25-158 11/17/2026
Prevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (R61/R33 Clinical Trial Optional)
Agency HHS-NIH11

This Notice of Funding Opportunity (NOFO) focuses on prevention and intervention strategies for fetal alcohol spectrum d...

Posted: 11/25/2024 View Details →
PAR-25-281 01/07/2028
Mood and Psychosis Symptoms during the Menopause Transition (R01 Clinical Trial Optional)
Agency HHS-NIH11

The purpose of this Notice of Funding Opportunity (NOFO) is to advance translational research to better understand the e...

Posted: 11/22/2024 View Details →
RFA-HL-26-019 12/23/2027
Catalyze Product Definition Medical Device prototype design/testing and disease target identification and assay development (R61/R33 - Clinical Trial Not Allowed)
Agency HHS-NIH11

The goal of the NHLBI Catalyze Program is to provide a comprehensive suite of support and services to facilitate the tra...

Posted: 11/22/2024 View Details →
PAR-25-291 01/07/2028
Utilizing Invasive Recording and Stimulating Opportunities in Humans to Advance Neural Circuitry Understanding of Mental Health Disorders (R21 Clinical Trial Optional)
Agency HHS-NIH11

Reissue of RFA-20-351.The purpose of this Notice of Funding Opportunity (NOFO) is to encourage applications to pursue in...

Posted: 11/22/2024 View Details →
PAR-25-282 01/07/2028
Mood and Psychosis Symptoms during the Menopause Transition (R21 Clinical Trial Optional)
Agency HHS-NIH11

The purpose of this Notice of Funding Opportunity (NOFO) is to advance translational research to better understand the e...

Posted: 11/22/2024 View Details →
PAR-25-290 01/07/2028
Utilizing Invasive Recording and Stimulating Opportunities in Humans to Advance Neural Circuitry Understanding of Mental Health Disorders (R01 Clinical Trial Optional)
Agency HHS-NIH11

The purpose of this Notice of Funding Opportunity (NOFO) is to encourage applications to pursue invasive neural recordin...

Posted: 11/22/2024 View Details →
RFA-HL-26-020 12/23/2027
Catalyze: Product Definition Medical Device Prototype Optimization (R33 - Clinical Trial Not Allowed)
Agency HHS-NIH11

The goal of the NHLBI Catalyze Program is to provide a comprehensive suite of support and services to facilitate the tra...

Posted: 11/22/2024 View Details →
RFA-HL-26-016 12/23/2027
Catalyze: Enabling Technologies and Transformative Platforms for HLBS Research (R33 - Clinical Trials Not Allowed)
Agency HHS-NIH11

The goal of the NHLBI Catalyze Program is to provide a comprehensive suite of support and services to facilitate the tra...

Posted: 11/22/2024 View Details →
PAR-25-226 11/19/2026
Seamless Early-Stage Clinical Drug Development (Phase 1 to 2a) for Novel therapeutic Agents for the Spectrum of Alzheimer's Disease (AD) and AD-related Dementias (ADRD) (UG3/UH3 Clinical Trial Required)
Agency HHS-NIH11

The purpose of this Notice of Funding Opportunity (NOFO) is to invite applications that bundle independent protocols for...

Posted: 11/22/2024 View Details →
RFA-OH-25-003 10/26/2028
Occupational Safety and Health Training Project Grants (T03)
Agency HHS-CDC-HHSCDCERA

The National Institute for Occupational Safety and Health (NIOSH), Centers for Disease Control and Prevention (CDC), inv...

Posted: 11/22/2024 View Details →
RFA-HL-26-018 12/23/2027
Catalyze: Product Definition for Small Molecules, Biologics, and Combination Products - Preliminary Product/Lead Series Identification and Combination Product Prototype (R33 - Clinical Trial Not Allowed)
Agency HHS-NIH11

The goal of the NHLBI Catalyze Program is to provide a comprehensive suite of support and services to facilitate the tra...

Posted: 11/22/2024 View Details →
RFA-HL-26-017 12/23/2027
Catalyze: Product Definition for Small Molecules, Biologics and Combination Products - Target Identification and Validation, and Preliminary Product/Lead Series Identification (R61/R33 Clinical Trials Not Allowed)
Agency HHS-NIH11

The goal of the NHLBI Catalyze Program is to provide a comprehensive suite of support and services to facilitate the tra...

Posted: 11/22/2024 View Details →
PAR-25-274 11/17/2026
Feasibility Clinical Trials of Mind and Body Interventions for NCCIH High Priority Research Topics (R34 Clinical Trial Required)
Agency HHS-NIH11

The goal of this notice of funding opportunity (NOFO) is to support feasibility trials of complementary and integrative ...

Posted: 11/21/2024 View Details →
PAR-25-268 11/17/2026
Investigator Initiated Clinical Trials of Complementary and Integrative Interventions Delivered Remotely or via mHealth (R01 Clinical Trial Required)
Agency HHS-NIH11

This Notice of Funding Opportunity (NOFO) encourages applications for investigator-initiated fully remotely delivered an...

Posted: 11/21/2024 View Details →
PAR-25-286 01/07/2028
Neuromodulation/Neurostimulation Device Development for Mental Health Applications (R21 Clinical Trial Not Allowed)
Agency HHS-NIH11

The purpose of this Notice of Funding Opportunity (NOFO) is to encourage applications seeking to develop the next genera...

Posted: 11/21/2024 View Details →
RFA-NS-25-016 06/17/2026
BRAIN Initiative: Promoting Health for All Through BRAIN Technology Partnerships (R34 - Clinical Trials Not Allowed)
Agency HHS-NIH11

The goal of this concept is to increase the impact of the BRAIN Initiative by targeted dissemination and integration of ...

Posted: 11/21/2024 View Details →
PAR-26-001 05/07/2027
Screening, Brief Intervention and Referral to Treatment or Prevention (SBIRT/P) for alcohol, tobacco, and other drugs (ATOD) use and misuse in adult populations that experience health disparities (R01, Clinical Trial Required)
Agency HHS-NIH11

The Office of Disease Prevention (ODP) and participating National Institutes of Health (NIH) Institutes, Centers, and Of...

Posted: 11/21/2024 View Details →
PAR-25-267 11/17/2026
NCCIH Multi-Site Feasibility Clinical Trials of Mind and Body Interventions (R01 Clinical Trial Required)
Agency HHS-NIH11

This notice of funding opportunity (NOFO) invites applications for investigator-initiated clinical trials of complementa...

Posted: 11/21/2024 View Details →
PAR-25-248 10/08/2027
Utilizing the PLCO Biospecimens Resource to Bridge Gaps in Cancer Etiology and Early Detection Research (U01 Clinical Trial Not Allowed)
Agency HHS-NIH11

This Funding Opportunity Announcement (FOA) encourages the submission of applications that propose to advance research i...

Posted: 11/21/2024 View Details →
PAR-25-148 01/07/2028
Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required)
Agency HHS-NIH11

The purpose of this Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions is to support smal...

Posted: 11/21/2024 View Details →
PAR-25-287 01/07/2028
Neuromodulation/Neurostimulation Device Development for Mental Health Applications (R01 Clinical Trial Not Allowed)
Agency HHS-NIH11

The purpose of this Notice of Funding Opportunity (NOFO) is to encourage applications seeking to develop the next genera...

Posted: 11/21/2024 View Details →
PAR-25-235 01/07/2027
Personal Health Informatics for Delivering Actionable Insights to Individuals (R01 Clinical Trial Optional)
Agency HHS-NIH11

The purpose of this Notice of Funding Opportunity (NOFO) is to advance the development of novel informatics and data sci...

Posted: 11/21/2024 View Details →
PAR-25-052 11/19/2026
NIH StrokeNet Clinical Trials and Biomarker Studies for Stroke Treatment, Recovery, and Prevention (UG3/UH3 Clinical Trial Optional)
Agency HHS-NIH11

This NOFO encourages applications for multi-site exploratory and confirmatory clinical trials focused on promising inter...

Posted: 11/20/2024 View Details →
PAR-25-135 10/14/2027
NCI Pathway to Independence Award (K99/R00 Clinical Trial Not Allowed)
Agency HHS-NIH11

The purpose of the NCI Pathway to Independence Award (K99/R00) program is to facilitate a timely transition of talented ...

Posted: 11/20/2024 View Details →
RFA-DA-26-034 11/18/2027
Chemical Countermeasures Research Program (CCRP) Initiative: Basic Research on The Deleterious Effects of Acute Exposure to Ultra-Potent Synthetic (UPS) Opioids (R01 Clinical Trial Not Allowed)
Agency HHS-NIH11

This notice of funding opportunity (NOFO) will support research towards understanding and mitigating the deleterious eff...

Posted: 11/20/2024 View Details →
PAR-25-038 09/07/2026
Cellular and Molecular Biology of Complex Brain Disorders (R01 Clinical Trial Not Allowed)
Agency HHS-NIH11

This Notice of Funding Opportunity (NOFO) encourages research on the biology of high-confidence risk factors associated ...

Posted: 11/18/2024 View Details →
PAR-25-066 09/07/2026
Social disconnection and Suicide Risk in Late Life (R21 Clinical Trial Optional)
Agency HHS-NIH11

This initiative seeks to solicit applications for research projects that address the link between social disconnection i...

Posted: 11/18/2024 View Details →
PAR-25-204 11/12/2027
NIDA Research Education Program for Clinical Researchers and Clinicians (R25 Clinical Trial Not Allowed)
Agency HHS-NIH11

The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH. The ove...

Posted: 11/18/2024 View Details →
PAR-25-112 09/07/2027
Advancement and Innovation in Measurement of Language Development and Predictors (R01 Clinical Trial Not Allowed)
Agency HHS-NIH11

The purpose of this notice of funding opportunity (NOFO) is to encourage community-engaged research that broadens the co...

Posted: 11/18/2024 View Details →
PAR-25-113 09/07/2027
Advancement and Innovation in Measurement of Language Development and Predictors (R21 Clinical Trial Not Allowed)
Agency HHS-NIH11

The purpose of this notice of funding opportunity (NOFO) is to encourage community-engaged research that broadens the co...

Posted: 11/18/2024 View Details →
PAR-25-228 09/07/2027
Investigator Initiated Innovation in Computational Genomics and Data Science (R01 Clinical Trial Not Allowed)
Agency HHS-NIH11

The purpose of this funding opportunity announcement (FOA) is to invite applications for a broad range of research effor...

Posted: 11/18/2024 View Details →
PAR-25-229 09/07/2027
Investigator Initiated Innovation in Computational Genomics and Data Science (R21 Clinical Trial Not Allowed)
Agency HHS-NIH11

The purpose of this funding opportunity announcement (FOA) is to invite applications for a broad range of research effor...

Posted: 11/18/2024 View Details →
PAR-25-105 01/07/2028
NIDCR Small Grant Program for New Investigators (R03 Clinical Trial Not Allowed)
Agency HHS-NIH11

This NIDCR Small Grant Program for New Investigators supports basic and clinical research conducted by scientists who ar...

Posted: 11/18/2024 View Details →
PA-25-125 01/07/2028
NICHD Small Research Grant Program (R03 Clinical Trial Required)
Agency HHS-NIH11

The NICHD Small Research Grant Program (Clinical Trial Required) supports clinical trials that fall within the NICHD mis...

Posted: 11/18/2024 View Details →
PAR-25-069 01/07/2027
Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R01 Clinical Trial Optional)
Agency HHS-NIH11

The goal of the proposed funding announcement is twofold, to promote preclinical and patient based studies examining the...

Posted: 11/18/2024 View Details →
PAR-25-243 01/07/2028
Basic Research in Cancer Health Disparities (R01 Clinical Trial Not Allowed)
Agency HHS-NIH11

This Notice of Funding Opportunity (NOFO) encourages grant applications from investigators interested in conducting basi...

Posted: 11/18/2024 View Details →
PAR-25-040 09/07/2026
Schizophrenia and related disorders during mid- to late-life (R21 Clinical Trial Optional)
Agency HHS-NIH11

Although the majority living with schizophrenia and related disorders are over 35 years old, including those first diagn...

Posted: 11/18/2024 View Details →
PAR-25-095 09/07/2026
Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R01 Clinical Trial Not Allowed)
Agency HHS-NIH11

Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) along with other participating In...

Posted: 11/18/2024 View Details →
PAR-25-065 09/07/2026
Novel Mechanism Research on Neuropsychiatric Symptoms (NPS) in Alzheimer's Dementia (R01 Clinical Trial Optional)
Agency HHS-NIH11

The goal of this Funding Opportunity Announcement (FOA) is to encourage applications for studies that will enhance knowl...

Posted: 11/18/2024 View Details →
PAR-25-070 01/07/2027
Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R21 Clinical Trial Not Allowed)
Agency HHS-NIH11

The goal of the proposed funding announcement is twofold, to promote preclinical and patient based studies examining the...

Posted: 11/18/2024 View Details →
PAR-25-064 09/07/2026
Novel Mechanism Research on Neuropsychiatric Symptoms (NPS) in Alzheimer's Dementia (R21 Clinical Trial Optional)
Agency HHS-NIH11

The goal of this Funding Opportunity Announcement (FOA) is to encourage applications for studies that will enhance knowl...

Posted: 11/18/2024 View Details →
PAR-25-096 09/07/2026
Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R21 Clinical Trials Not Allowed)
Agency HHS-NIH11

Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) along with other participating In...

Posted: 11/18/2024 View Details →
PAR-25-244 11/16/2027
Basic Research in Cancer Health Disparities (R21 Clinical Trial Not Allowed)
Agency HHS-NIH11

This Notice of Funding Opportunity (NOFO) encourages grant applications from investigators interested in conducting basi...

Posted: 11/18/2024 View Details →
PAR-25-039 09/07/2026
Schizophrenia and related disorders during mid- to late-life (R01 Clinical Trial Optional)
Agency HHS-NIH11

Although the majority living with schizophrenia and related disorders are over 35 years old, including those first diagn...

Posted: 11/18/2024 View Details →
PAR-25-067 09/07/2026
Social disconnection and Suicide Risk in Late Life (R01 Clinical Trial Optional)
Agency HHS-NIH11

This initiative seeks to solicit applications for research projects that address the link between social disconnection i...

Posted: 11/18/2024 View Details →
PAR-25-037 09/07/2026
Cellular and Molecular Biology of Complex Brain Disorders (R21 Clinical Trial Not Allowed)
Agency HHS-NIH11

This Notice of Funding Opportunity (NOFO) encourages research on the biology of high confidence risk factors associated ...

Posted: 11/18/2024 View Details →
PAR-25-124 01/07/2028
NCMRR Early Career Research Award (R03 Clinical Trial Optional)
Agency HHS-NIH11

The National Center for Medical Rehabilitation Research (NCMRR) Early Career Research (ECR) Award (R03) is intended to s...

Posted: 11/18/2024 View Details →
PA-25-126 05/24/2026
NICHD Small Research Grant Program (R03 Basic Experimental Studies with Humans Required)
Agency HHS-NIH11

The NICHD Small Research Grant Program (R03Basic Experimental Studies with HumansRequired) supports clinical trials that...

Posted: 11/18/2024 View Details →
PA-25-168 05/04/2028
Ruth L. Kirschstein National Research Service Award (NRSA) Institutional Research Training Grant (Parent T32)
Agency HHS-NIH11

The National Institutes of Health (NIH) will award Ruth L. Kirschstein National Research Service Award (NRSA) Institutio...

Posted: 11/15/2024 View Details →
PAR-25-256 01/07/2027
Developing novel theory and methods for understanding the genetic architecture of complex human traits (R21 Clinical Trial Not Allowed)
Agency HHS-NIH11

The goal of this NOFO is to support R21 applications for novel theory and methods development that better delineate how ...

Posted: 11/15/2024 View Details →
PAR-25-273 01/07/2028
Development of Animal Models and Related Biological Materials for Research (R21 Clinical Trial Not Allowed)
Agency HHS-NIH11

This notice of funding opportunity (NOFO) encourages innovative research to develop, improve, characterize, and preserve...

Posted: 11/15/2024 View Details →
RFA-MH-26-170 02/08/2027
BRAIN Initiative: Development and Validation of Novel Tools to Probe Cell-Specific and Circuit-Specific Processes in the Brain (R01 Clinical Trial Not Allowed)
Agency HHS-NIH11

The purpose of this Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative is to encourage app...

Posted: 11/15/2024 View Details →
PAR-25-255 11/05/2026
Developing novel theory and methods for understanding the genetic architecture of complex human traits (R01 Clinical Trial Not Allowed)
Agency HHS-NIH11

The goal of this NOFO is to support applications for novel theory and methods development that enable better understandi...

Posted: 11/15/2024 View Details →
PAR-25-203 01/07/2028
Focused Technology Research and Development (R01 Clinical Trial Not Allowed)
Agency HHS-NIH11

This Notice of Funding Opportunity (NOFO) supports projects relevant to the NIGMS mission that focus solely on the devel...

Posted: 11/14/2024 View Details →
RFA-ES-25-002 04/20/2027
Environmental Health Sciences Core Centers Program (P30 Clinical Trials Optional)
Agency HHS-NIH11

This Notice of Funding Opportunity Announcement (NOFO) invites grant applications for Environmental Health Sciences Core...

Posted: 11/14/2024 View Details →
25-510 03/03/2027
Coupling, Energetics, and Dynamics of Atmospheric Regions
Agency NSF

The Coupling, Energetics, and Dynamics of Atmospheric Regions (CEDAR) program supports research to increase our understa...

Posted: 11/14/2024 View Details →
PAR-25-202 05/12/2026
Technology Development Research for Establishing Feasibility and Proof of Concept (R21 - Clinical Trial Not Allowed)
Agency HHS-NIH11

This Notice of Funding Opportunity (NOFO)supports exploratory research leading to proof of concept for the development o...

Posted: 11/14/2024 View Details →
PAR-25-170 06/22/2026
Digital Health Technology Derived Biomarkers and Outcome Assessments for Remote Monitoring and Endpoint Development (UG3/UH3 - Clinical Trial Optional)
Agency HHS-NIH11

The purpose of this proposed Notice of Funding Announcement (NOFO) is to support development of biomarkers or clinical o...

Posted: 11/13/2024 View Details →
PAR-25-027 01/07/2028
NIDCR Dentist Scientist Career Transition Award for Intramural Investigators (K22 Clinical Trial Not Allowed)
Agency HHS-NIH11

The purpose of the NIDCR Dentist Scientist Career Transition Award for Intramural Investigators (K22) program is to faci...

Posted: 11/12/2024 View Details →
PA-25-253 09/07/2028
Exploratory Grants in Cancer Control (R21 Clinical Trial Optional)
Agency HHS-NIH11

This funding opportunity announcement (FOA) encourages the submission of exploratory/developmental research grant (R21) ...

Posted: 11/12/2024 View Details →
PAR-25-167 01/07/2027
Cancer Prevention and Control Clinical Trials Grant Program (R01 Clinical Trial Required)
Agency HHS-NIH11

Through this notice of funding opportunity (NOFO), the National Cancer Institute (NCI) invites applications for support ...

Posted: 11/12/2024 View Details →
PAR-25-081 01/07/2027
National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required)
Agency HHS-NIH11

Through this Notice of Funding Opportunity, the National Cancer Institute (NCI) seeks research projects that implement e...

Posted: 11/12/2024 View Details →
PAR-25-136 01/07/2028
Laboratories to Optimize Digital Health (R01 Clinical Trial Required)
Agency HHS-NIH11

NIMH seeks applications for innovative research projects to test strategies to increase the reach, efficiency, effective...

Posted: 11/07/2024 View Details →
PA-25-172 01/07/2028
Modular R01s in Cancer Control and Population Sciences (R01 Clinical Trial Optional)
Agency HHS-NIH11

This Notice of Funding Opportunity (NOFO) encourages applications for research in cancer control and population sciences...

Posted: 11/07/2024 View Details →
PAR-25-234 01/07/2028
NINDS Ruth L. Kirschstein National Research Service Award (NRSA) for Training of Postdoctoral Fellows (F32 Clinical Trial Not Allowed)
Agency HHS-NIH11

The purpose of this award is to support outstanding scientific training of highly promising postdoctoral candidates with...

Posted: 11/07/2024 View Details →
PAR-25-049 07/09/2026
NIH SIREN Neurologic Clinical Trials (UG3/UH3 - Clinical Trial Required)
Agency HHS-NIH11

This announcement (NOFO) encourages applications for multi-center clinical trials focused on neurological emergencies. S...

Posted: 11/07/2024 View Details →
PAR-25-221 01/07/2027
Population Approaches to Reducing Alcohol-related Cancer Risk (R01 Clinical Trial Optional)
Agency HHS-NIH11

This Notice of Funding Opportunity (NOFO) aims to support research on interdisciplinary population approaches to increas...

Posted: 11/06/2024 View Details →
PAR-25-227 01/07/2028
Natural History of Disorders Screenable in the Newborn Period (R01 Clinical Trial Optional)
Agency HHS-NIH11

The purpose of this Notice of Funding Opportunity (NOFO) encourages applications that will expand knowledge of the natur...

Posted: 11/06/2024 View Details →
PAR-25-145 01/07/2028
Clinical Characterization of Cancer Therapy-induced Adverse Sequelae and Mechanism-based Interventional Strategies (R01 Clinical Trial Optional)
Agency HHS-NIH11

The purpose of this Funding Opportunity Announcement (FOA) is to support collaborative research projects designed to add...

Posted: 11/06/2024 View Details →
PAR-24-325 09/07/2027
Bioengineering Partnerships with Industry (U01 Clinical Trial Optional)
Agency HHS-NIH11

This Funding Opportunity Announcement (FOA) solicits applications from research partnerships formed by academic and indu...

Posted: 11/06/2024 View Details →
PAR-24-306 09/07/2026
Research Projects to Enhance Applicability of Mammalian Models for Translational Research (R01 Clinical Trial Not Allowed)
Agency HHS-NIH11

Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) invites applications for projects...

Posted: 11/06/2024 View Details →
PAR-25-153 09/07/2026
Assay development and screening for discovery of chemical probes, drugs or immunomodulators (R01 Clinical Trial Not Allowed)
Agency HHS-NIH11

Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) solicits applications for identif...

Posted: 11/06/2024 View Details →
PAR-24-311 01/07/2028
Molecular Imaging of Inflammation in Cancer (R01 Clinical Trial Not Allowed)
Agency HHS-NIH11

The purpose of this Notice of Funding Opportunity (NOFO) is to invite research grant applications (R01) for the developm...

Posted: 11/06/2024 View Details →
PAR-25-175 01/07/2028
Integration of Imaging and Fluid-Based Tumor Monitoring in Cancer Therapy (R01 Clinical Trial Optional)
Agency HHS-NIH11

Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) seeks research project (R01) gran...

Posted: 11/06/2024 View Details →
PAR-24-321 11/12/2027
NIA Academic Leadership Career Award (K07 Independent Clinical Trial Not Allowed)
Agency HHS-NIH11

The objective of the NIA Academic Leadership Career Award (K07) is to provide support for established investigators who ...

Posted: 11/06/2024 View Details →
PAS-25-205 01/06/2028
Stimulating Hematology Investigation: New Endeavors (SHINE) (R01 Clinical Trial Not Allowed)
Agency HHS-NIH11

The Stimulating Hematology Investigation: New Endeavors (SHINE) program is intended to promote innovative, high-quality ...

Posted: 11/06/2024 View Details →
PAR-25-079 01/07/2027
Academic-Industrial Partnerships (AIP) to Translate and Validate In Vivo Imaging Systems (R01 Clinical Trial Optional)
Agency HHS-NIH11

Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) intends to stimulate translation ...

Posted: 11/06/2024 View Details →
PAR-25-103 10/25/2027
Cancer Prevention and Control Clinical Trials Planning Grant Program (U34 Clinical Trials Optional)
Agency HHS-NIH11

The purpose of this NOFO is to facilitate well planned clinical trials across the cancer prevention and control spectrum...

Posted: 11/05/2024 View Details →
RFA-NS-25-022 09/28/2026
BRAIN Initiative: Clinical Studies to Advance Next-Generation Devices for Recording and Modulation in the Human Central Nervous System (UH3 Clinical Trial Optional)
Agency HHS-NIH11

The purpose of this announcement is to encourage investigators to pursue a small clinical trial to obtain critical infor...

Posted: 11/05/2024 View Details →
PAR-25-104 10/25/2027
Cancer Prevention and Control Clinical Trials Planning Grant Program (R34 Clinical Trials Optional)
Agency HHS-NIH11

The purpose of this FOA is to facilitate well planned clinical trials across the cancer prevention and control spectrum ...

Posted: 11/05/2024 View Details →
RFA-NS-25-021 09/28/2026
BRAIN Initiative: Next-Generation Devices for Recording and Modulation in the Human Central Nervous System (UG3/UH3 Clinical Trial Optional)
Agency HHS-NIH11

The purpose of this announcement is to encourage investigators to pursue translational activities and small clinical stu...

Posted: 11/05/2024 View Details →
PAR-25-225 10/20/2027
Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Neurotherapeutic Agent Characterization and In vivo Efficacy Studies (R61/R33 Clinical Trial Not Allowed)
Agency HHS-NIH11

Reissue PAR-21-122. This NOFO provides funding to conduct pharmacodynamic, pharmacokinetic, and in vivo efficacy studies...

Posted: 11/04/2024 View Details →
PAR-25-077 10/16/2026
CCRP Initiative: NIH Countermeasures Against Chemical Threats (CounterACT) Basic Research on Chemical Threats that Affect the Nervous System (R01 Clinical Trial Not Allowed)
Agency HHS-NIH11

This announcement invites applications for basic research projects on chemical warfare agents, toxic industrial chemical...

Posted: 11/01/2024 View Details →
Browse More

See grants closing soon or explore the full intelligence feed.

⏱ Closing Soon → All Months → Intelligence Feed →
GrantMetric Intelligence Systems — Independent federal grant intelligence platform. Not affiliated with Grants.gov, the U.S. Department of Health & Human Services, or any government agency. Grant data is sourced from the Grants.gov API for informational purposes only; always verify opportunity details directly with the funding agency before applying. Some links on this site are affiliate links — we may earn a commission at no additional cost to you. Full Disclaimer  ·  Last Reviewed: May 2026  ·  Data Methodology